{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:37:24Z","timestamp":1760297844980},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T00:00:00Z","timestamp":1185840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s12016-007-0012-0","type":"journal-article","created":{"date-parts":[[2007,7,30]],"date-time":"2007-07-30T15:48:32Z","timestamp":1185810512000},"page":"153-158","source":"Crossref","is-referenced-by-count":20,"title":["Pulmonary Hypertension, Antiphospholipid Antibodies, and Syndromes"],"prefix":"10.1007","volume":"32","author":[{"given":"Ronald A.","family":"Asherson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,31]]},"reference":[{"key":"12_CR1","unstructured":"Humbert M (2007) Post-marketing surveillance survey of use of bosetan in pulmonary arterial hypertension. Oral presentation ATS annual meeting. TRAX data on file. Actelion"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","volume":"9","author":"JL Vianna","year":"1994","unstructured":"Vianna JL, Khamashta MA, Ordi-Ros J et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European multicentre study of 114 patients. Am J Med 9:3\u20139","journal-title":"Am J Med"},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4471-3666-8_27","volume-title":"Hughes syndrome: the antiphospholipid syndrome","author":"GA McCarty","year":"2000","unstructured":"McCarty GA (2000) Vascular pathology of the antiphospholipid syndrome. In: Khamashta MA (ed) Hughes syndrome: the antiphospholipid syndrome. Springer, London, pp 263\u2013280"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT (2002) The antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46:1019\u20131027","journal-title":"Arthritis Rheum"},{"issue":"Suppl S","key":"12_CR5","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","volume":"43","author":"G Simonneau","year":"2004","unstructured":"Simonneau G, Galie N, Rubin LJ et al (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(Suppl S):5S\u201312S","journal-title":"J Am Coll Cardiol"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.81.6.1735","volume":"81","author":"KM Moser","year":"1990","unstructured":"Moser KM, Auger WR, Fedullo PF (1990) Chronic major vessel thromboembolic pulmonary hypertension. Circulation 81:1735\u20131743","journal-title":"Circulation"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0022-5223(19)33748-1","volume":"106","author":"SW Jamieson","year":"1993","unstructured":"Jamieson SW, Auger WR, Fedullo PF et al (1993) Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 106:116\u2013127","journal-title":"J Thorac Cardiovasc Surg"},{"key":"12_CR8","first-page":"772","volume":"23","author":"J Sandoval","year":"1996","unstructured":"Sandoval J, Amigo MC, Barragan R et al (1996) Primary antiphospholipid syndrome presenting as chronic thromboembolic hypertension. Treatment with thromboendarterectomy. J Rheumatol 23:772\u2013775","journal-title":"J Rheumatol"},{"issue":"4","key":"12_CR9","first-page":"252","volume":"8","author":"D Bendayan","year":"2006","unstructured":"Bendayan D, Shitrit D, Kramer MR (2006) Pulmonary arterial hypertension associated with autoimmune disease: a single medical center experience. Isr Med Assoc J 8(4):252\u2013254","journal-title":"Isr Med Assoc J"},{"issue":"4","key":"12_CR10","first-page":"277","volume":"8","author":"R Cervera","year":"2006","unstructured":"Cervera R, Asherson RA (2006) Primary pulmonary arterial hypertension and the systemic autoimmune diseases. Isr Med Assoc J 8(4):277\u2013279 (editorial)","journal-title":"Isr Med Assoc J"},{"key":"12_CR11","first-page":"690","volume":"23","author":"PJ Holt","year":"1980","unstructured":"Holt PJ, Clague RB, Hay FC, Nineham IJ, Wade EG (1980) Is idiopathic pulmonary hypertension a connective tissue disease? Arthritis Rheum 23:690 (abstract)","journal-title":"Arthritis Rheum"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0735-1097(86)80301-1","volume":"8","author":"S Rich","year":"1986","unstructured":"Rich S, Kieras K, Hait K, Groves BM, Stobo JD, Brundage BH (1986) Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8:1307\u20131311","journal-title":"J Am Coll Cardiol"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0002-9343(92)90238-7","volume":"93","author":"RA Isern","year":"1992","unstructured":"Isern RA, Yaneva M, Weiner E et al (1992) Autoantibodies in patients with primary pulmonary hypertension; association with anti-Ku. Am J Med 93:307\u2013312","journal-title":"Am J Med"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000163936","volume":"63","author":"H Yanai-Landau","year":"1995","unstructured":"Yanai-Landau H, Amital H, Bar-Dayan Y et al (1995) Autoimmune aspects of primary pulmonary hypertension. Pathobiology 63:71\u201375","journal-title":"Pathobiology"},{"key":"12_CR15","first-page":"286","volume":"23","author":"M Karmochkine","year":"1996","unstructured":"Karmochkine M, Cacoub P, Dorent R et al (1996) High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. J Rheumatol 23:286\u2013290","journal-title":"J Rheumatol"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1183\/09031936.05.00045705","volume":"26","author":"MR Nicolls","year":"2005","unstructured":"Nicolls MR, Tarasevicience-Stewart L, Rai PR, Badesch DB, Voelkel NF (2005) Autoimmunity and pulmonary hypertension: a perspective. Eur Respir J 26:1110\u20131118","journal-title":"Eur Respir J"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","volume":"1","author":"G Zandman-Goddard","year":"2002","unstructured":"Zandman-Goddard G, Shoenfeld Y (2002) HIV and autoimmunity. Autoimmun Rev 1:329\u2013337","journal-title":"Autoimmun Rev"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-130-6-199903160-00014","volume":"130","author":"MM Hoeper","year":"1999","unstructured":"Hoeper MM, Niedermeyer J, Hoffmeyer F, Flemming P, Fabel H (1999) Pulmonary hypertension after splenectomy? Ann Intern Med 130:506\u2013509","journal-title":"Ann Intern Med"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1183\/09031936.03.00018203","volume":"22","author":"L Korniszewski","year":"2003","unstructured":"Korniszewski L, Kurzyna M, Stolarski B, Torbicki A, Smerdel A, Ploski R (2003) Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur Respir J 22:709\u2013711","journal-title":"Eur Respir J"},{"key":"12_CR20","volume-title":"Familial primary pulmonary hypertension","author":"J Lloyd","year":"1997","unstructured":"Lloyd J, Newman J (1997) Familial primary pulmonary hypertension. Marcel Dekker, New York"},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM200108023450511","volume":"345","author":"J Loscalzo","year":"2001","unstructured":"Loscalzo J (2001) Genetic clues to the cause of primary pulmonary hypertension. N Engl J Med 345:367\u2013371","journal-title":"N Engl J Med"},{"key":"12_CR22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng0397-277","volume":"15","author":"WC Nichols","year":"1997","unstructured":"Nichols WC, Koller DL, Slovis B et al (1997) Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31\u201332. Nat Genet 15:277\u2013280","journal-title":"Nat Genet"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"2002","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4 regulatory CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2002:531\u2013562","journal-title":"Annu Rev Immunol"},{"key":"12_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","volume":"67","author":"Z Deng","year":"2000","unstructured":"Deng Z, Morse JH, Slager S et al (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-11 gene. Am J Hum Genet 67:737\u2013744","journal-title":"Am J Hum Genet"},{"key":"12_CR25","first-page":"462","volume":"25","author":"VS Negi","year":"1998","unstructured":"Negi VS, Tripathy NK, Misra R, Nityanand S (1998) Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 25:462\u2013466","journal-title":"J Rheumatol"},{"key":"12_CR26","first-page":"427","volume":"1","author":"Y Renaudineau","year":"2002","unstructured":"Renaudineau Y, Dugue C, Dueymes M, Youinou P (2002) Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 1:427\u2013438","journal-title":"Autoimmun Rev"},{"key":"12_CR27","first-page":"885","volume":"42","author":"N Sasaki","year":"2002","unstructured":"Sasaki N, Kurose AQ, Inoue H, Sawai TA (2002) Possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension. Ryumachi 42:885\u2013894","journal-title":"Ryumachi"},{"key":"12_CR28","first-page":"681","volume":"11","author":"F Longo","year":"1993","unstructured":"Longo F, Saletta S, Lepore L, Pennnesi M (1993) Localized scleroderma after infection with Epstein\u2013Barr virus. Clin Exp Rheumatol 11:681\u2013683","journal-title":"Clin Exp Rheumatol"},{"key":"12_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","volume":"31","author":"CM Magro","year":"2004","unstructured":"Magro CM, Nuovo G, Ferri C, Crowson AN, Giuggioli D, Sebastiani M (2004) Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31:43\u201350","journal-title":"J Cutan Pathol"},{"key":"12_CR30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/qjmed\/91.5.375a","volume":"91","author":"C Ferri","year":"1998","unstructured":"Ferri C, Longombardo G, Mugnaini P (1998) Hepatitis E virus and systemic sclerosis. QJM 91:375","journal-title":"QJM"},{"key":"12_CR31","first-page":"718","volume":"17","author":"C Ferri","year":"1999","unstructured":"Ferri C, Zakrewska K, Longombardo G et al (1999) Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 17:718\u2013720","journal-title":"Clin Exp Rheumatol"},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/313712","volume":"30","author":"L Harel","year":"2000","unstructured":"Harel L, Strausberg R, Rudich H, Cohen AH, Amir J (2000) Raynaud\u2019s phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitis syndrome. Clin Infect Dis 30:500\u2013503","journal-title":"Clin Infect Dis"},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s100670070031","volume":"19","author":"M Abu-Shakra","year":"2000","unstructured":"Abu-Shakra M, Sukenik S, Buskila D (2000) Systemic sclerosis: another rheumatic disease associated with hepatitis C virus infection. Clin Rheumatol 19:378\u2013380","journal-title":"Clin Rheumatol"},{"key":"12_CR34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1529-0131(199902)42:2<389::AID-ANR23>3.0.CO;2-P","volume":"42","author":"M Neidhart","year":"1999","unstructured":"Neidhart M, Kuchen S, Distler O et al (1999) Increased serum levels of antibodies against cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis Rheum 42:389\u2013392","journal-title":"Arthritis Rheum"},{"issue":"4","key":"12_CR35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000236437","volume":"100","author":"M Miyata","year":"1993","unstructured":"Miyata M, Suzuki K, Sakuma F et al (1993) Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol 100(4):351\u2013354","journal-title":"Int Arch Allergy Immunol"},{"key":"12_CR36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02030976","volume":"5","author":"P Hainaut","year":"1986","unstructured":"Hainaut P, Lauvenne E, Magy JM, Lebacq EG (1986) Circulating lupus anticoagulant and pulmonary hypertension associated with mixed connective tissue disease. Clin Rheumatol 5:96\u2013101","journal-title":"Clin Rheumatol"},{"key":"12_CR37","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bmj.287.6398.1024-a","volume":"287","author":"RA Asherson","year":"1983","unstructured":"Asherson RA, Mackworth-Young CG, Boey CG et al (1983) Pulmonary Hypertension in systemic lupus erythematosus. Br Med J 287:1024\u20131025","journal-title":"Br Med J"},{"key":"12_CR38","first-page":"416","volume":"12","author":"RA Asherson","year":"1986","unstructured":"Asherson RA, Hackett D, Gharavi AE, Harris EN, Kennedy HG, Hughes GRV (1986) Pulmonary hypertension in systemic lupus erythematosus. A report of three cases. Rheumatol 12:416\u2013420","journal-title":"Rheumatol"},{"key":"12_CR39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","volume":"68","author":"D Alarcon Segovia","year":"1989","unstructured":"Alarcon Segovia D, Deleze M, Oria CV et al (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine (Baltimore) 68:353\u2013365","journal-title":"Medicine (Baltimore)"},{"key":"12_CR40","first-page":"1292","volume":"17","author":"RA Asherson","year":"1990","unstructured":"Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GRV (1990) Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17:1292\u20131298","journal-title":"J Rheumatol"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2169\/internalmedicine.33.540","volume":"33","author":"M Sato","year":"1994","unstructured":"Sato M, Okazaki H, Okamoto H et al (1994) Pulmonary hypertension in systemic lupus eythematosus; report of an autopsied case. Intern Med 33:540\u2013542","journal-title":"Intern Med"},{"key":"12_CR42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/000331979704800213","volume":"48","author":"H Nagai","year":"1997","unstructured":"Nagai H, Yasuma K, Katsuki T et al (1997) Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report. Angiology 48:183\u2013187","journal-title":"Angiology"},{"key":"12_CR43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/art.1780350616","volume":"35","author":"ME Luchi","year":"1992","unstructured":"Luchi ME, Asherson RA, Lahita RG (1992) Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Asssociation with antiphospholipid antibodies. Arthritis Rheum 35:700\u2013705","journal-title":"Arthritis Rheum"},{"key":"12_CR44","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/art.1780371018","volume":"37","author":"J Mata De la","year":"1994","unstructured":"De la Mata J, Gomez-Sanchez MA, Aranaza M, Gomez-Reino JJ (1994) Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum 37:1528\u20131533","journal-title":"Arthritis Rheum"},{"key":"12_CR45","first-page":"869","volume":"41","author":"M Rana","year":"2001","unstructured":"Rana M, Endo H, Watabe H, Tanaka S, Kondo H (2001) A case of primary antiphospholipid syndrome complicated with pulmonary hypertension. Ryumachi 41:869\u2013874","journal-title":"Ryumachi"},{"key":"12_CR46","first-page":"199","volume":"23","author":"N Assous","year":"2005","unstructured":"Assous N, Allanore Y, Batteux F et al (2005) Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 23:199\u2013204","journal-title":"Clin Exp Rheumatol"},{"key":"12_CR47","unstructured":"Asherson RA, Shepselovich, D, Cervera R, Shoenfeld Y (2006) Non thrombotic manifestations of the antiphospholipid syndrome: away from thrombosis? Editorial J Rheumatol (in press)"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0012-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-0012-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0012-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T12:58:48Z","timestamp":1587819528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-0012-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,31]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-0012-0","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,31]]}}}